Abstract
ObjectiveTo compare corneal biomechanical properties, measured by a newly developed tonometer (Corneal Visualization Scheimpflug Technology, Corvis ST), in untreated primary open angle glaucoma (POAG) patients, POAG patients with long-term topical prostaglandin analog (PGA) therapy and in normal controls. Further is to investigate the potential effects of PGA on corneal biomechanics.MethodsIn this case-control study, 35 consecutive medication naïve eyes with POAG, 34 POAG eyes with at least 2 years treatment by PGA and 19 normal eyes were included. Intraocular pressure (IOP), central corneal thickness (CCT) and corneal biomechanical parameters, including deformation amplitude (DA), applanation time (AT1 and AT2), applanation length (AL1 and AL2), applanation velocity (AV1 and AV2), and peak distance and radius were measured using Corvis ST. Axial length and corneal curvature were measured with partial coherence interferometry (IOLMaster, Zeiss, Germany). General linear model analysis was performed to investigate the corneal biomechanical property changes among the normal controls, newly diagnosed POAG patients and POAG patients with long-term PGA treatment, and among the subgroups of different types of PGA treatment, including bimatoprost, latanoprost and travoprost. Furthermore, pairwise comparisons using Bonferroni correction for least squares means were employed.ResultsAT1 (p<0.0001), AV1 (p<0.0001), AT2 (p = 0.0001), AV2 (p<0.0001) and DA (p = 0.0004) in newly diagnosed glaucoma patients were significantly different from those in normal subjects and in patients underwent at least 2 years topical PGA therapy after adjusting for age and gender. After adjusting for age, gender, IOP, CCT, axial length and corneal curvature, a significant difference was detected for DA between glaucoma patients without PGA treatment and patients with long-term PGA therapy (p = 0.0387). Furthermore, there were no statistical significant differences in all of the corneal biomechanical parameters among the 3 types of PGA therapy subgroups, namely bimatoprost, latanoprost and travoprost.ConclusionsSignificant changes in corneal deformation parameters were found among untreated POAG patients, POAG patients with long-term topical PGA therapy and normal controls. Long-term topical PGA treatment might have a direct effect on corneal biomechanical properties in addition to the indirect effect owing to the PGA-induced IOP reduction and CCT decrease on corneal dynamic properties.
Highlights
Glaucoma is a leading cause of visual impairment and blindness worldwide
After adjusting for age, gender, intraocular pressure (IOP), central corneal thickness (CCT), axial length and corneal curvature, a significant difference was detected for deformation amplitude (DA) between glaucoma patients without prostaglandin analogs (PGA) treatment and patients with long-term PGA therapy (p = 0.0387)
Significant changes in corneal deformation parameters were found among untreated primary open angle glaucoma (POAG) patients, POAG patients with long-term topical PGA therapy and normal controls
Summary
Glaucoma is a leading cause of visual impairment and blindness worldwide. It has been universally acknowledged that intraocular pressure (IOP) is the most important risk factor for the occurrence and progression of glaucoma [1]. Topical medical therapy is the initial treatment for glaucoma [2]. The prostaglandin analogs (PGA) are highly effective first-line anti-glaucoma agents. Besides the ocular hypotensive effect, PGA can decrease the central corneal thickness (CCT) after long-term topical usage [3, 4]. CCT reduction may result from the degradation of collagen owing to activation of prostaglandin E receptors in the corneal stroma [3]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.